Posted by Michael Wonder on 08 Oct 2020
Regeneron asks FDA for emergency approval for drug that Trump claimed cured him
7 October 2020 - The company said that doses of the unproven treatment would be available for 50,000 patients. It’s impossible to know whether it helped the president.
The drug maker Regeneron said on Wednesday evening that it had submitted an application to the FDA for emergency approval of the experimental antibody cocktail that President Trump had praised just hours earlier without evidence as a “cure” for the coronavirus.
The company said that at first, access to the treatment would be extremely limited, with only enough doses for 50,000 patients, a far cry from the “hundreds of thousands” of doses that Mr. Trump said in a video released Wednesday he would soon be making available to Americans free of charge.
